BreathDX.ai

Curated by Signal

Provider of molecular analysis of exhaled breath for diagnostic testing solutions

Overview

Provider of molecular analysis of exhaled breath for diagnostic testing solutions. It provides a micro gas chromatography based test which allows for non invasive detection of various illnesses by analyzing exhaled breath for volatile organic compounds. It offers a medical diagnostics focusing on early noninvasive cancer detection through breath analysis.

Key facts

Founded: 2019
Headquarters: United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

OMGenomics
Data visualization software for genomics
Life Sciences TechnologyRedwood City, United States
Integrity Tracking
Personal emergency response systems
Life Sciences TechnologyBoca Raton, United States
Proficient Learning
Sales training & technology solutions provider for life science professionals
Life Sciences TechnologyWilmington, United States

About BreathDX.ai

What does BreathDX.ai do?

Provider of molecular analysis of exhaled breath for diagnostic testing solutions.

Where is BreathDX.ai headquartered?

BreathDX.ai is headquartered in United States.

When was BreathDX.ai founded?

BreathDX.ai was founded in 2019.

Which sector is BreathDX.ai in?

BreathDX.ai operates in Life Sciences Technology.

Who are BreathDX.ai's competitors?

Companies similar to BreathDX.ai include OMGenomics, Integrity Tracking, and Proficient Learning.